Author
Listed:
- Yota Yasumizu
(Dana-Farber Cancer Institute Harvard Medical School)
- Hasan Rajabi
(Dana-Farber Cancer Institute Harvard Medical School)
- Caining Jin
(Dana-Farber Cancer Institute Harvard Medical School)
- Tsuyoshi Hata
(Dana-Farber Cancer Institute Harvard Medical School
Osaka University, Suita)
- Sean Pitroda
(University of Chicago)
- Mark D. Long
(Department of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center)
- Masayuki Hagiwara
(Dana-Farber Cancer Institute Harvard Medical School)
- Wei Li
(Dana-Farber Cancer Institute Harvard Medical School)
- Qiang Hu
(Department of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center)
- Song Liu
(Department of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center)
- Nami Yamashita
(Dana-Farber Cancer Institute Harvard Medical School)
- Atsushi Fushimi
(Dana-Farber Cancer Institute Harvard Medical School)
- Ling Kui
(Dana-Farber Cancer Institute Harvard Medical School)
- Mehmet Samur
(Dana-Farber Cancer Institute Harvard Medical School)
- Masaaki Yamamoto
(Dana-Farber Cancer Institute Harvard Medical School
Osaka University, Suita)
- Yan Zhang
(Dana-Farber Cancer Institute Harvard Medical School)
- Ning Zhang
(Dana-Farber Cancer Institute Harvard Medical School)
- Deli Hong
(Dana-Farber Cancer Institute Harvard Medical School)
- Takahiro Maeda
(Keio University School of Medicine Shinjuku-ku)
- Takeo Kosaka
(Keio University School of Medicine Shinjuku-ku)
- Kwok K. Wong
(New York University Langone Medical Center)
- Mototsugu Oya
(Keio University School of Medicine Shinjuku-ku)
- Donald Kufe
(Dana-Farber Cancer Institute Harvard Medical School)
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Suggested Citation
Yota Yasumizu & Hasan Rajabi & Caining Jin & Tsuyoshi Hata & Sean Pitroda & Mark D. Long & Masayuki Hagiwara & Wei Li & Qiang Hu & Song Liu & Nami Yamashita & Atsushi Fushimi & Ling Kui & Mehmet Samur, 2020.
"Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer,"
Nature Communications, Nature, vol. 11(1), pages 1-1, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-14808-w
DOI: 10.1038/s41467-020-14808-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-14808-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.